Unlocking the Future of the Generalized Anxiety Disorder Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the Generalized Anxiety Disorder market right now?
The market size for generalized anxiety disorder has been experiencing consistent expansion in the past few years. It is set to rise from $7.76 billion in 2024 to $8.01 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 3.2%. Factors contributing to this growth during the historic period include increased awareness around mental health, advancements in pharmaceuticals, cognitive-behavioral therapy (cbt), and changes to more stressful lifestyles.
How fast Is the generalized anxiety disorder market expected to grow, and what’s its future value?
The size of the market for generalized anxiety disorder is predicted to experience consistent expansion in the coming years, reaching $9.32 billion in 2029 with a 3.9% Compound Annual Growth Rate (CAGR). The anticipated growth in the forecast period is credited to advances in digital mental health solutions, genetic research, integrated healthcare models and global mental health awareness initiatives. Key factors driving this trend in the forecast period are a holistic approach to treatment, cultural competency, early detection, and the use of artificial intelligence (AI) in diagnosis.
Get your generalized anxiety disorder market report here!
https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report
What are the leading drivers of growth in the generalized anxiety disorder market?
The healthcare industry is experiencing an increased growth in the generalized anxiety disorder market due to a surge in cases of mental illnesses. A mental disorder, also referred to as mental illness, is a vast array of conditions that impact an individual’s overall mental health, including their thoughts, feelings, behaviour and wellbeing. It’s common for mental health disorders to coincide with generalized anxiety disorder, such as panic disorder, PTSD, phobias, and OCD, the management of which is a necessity for fostering healthy relationships and ameliorating an individual’s quality of life. According to a survey called Stress in America 2023, published by the American Psychological Association, people between the ages of 35 and 44 experienced a marked increase in mental health diagnoses in November 2023 – from 31% up to 45%. Meanwhile, adults from 18 to 34, although having the highest rate of mental illnesses in 2023 at 50%, the growth rate wasn’t as significant. As a result of this uptick in mental health disorder cases, the generalized anxiety disorder market is being propelled forward.
Generalized Anxiety Disorder Market Driver: Growth Boost in The Generalized Anxiety Disorder Market due to Government Initiatives
What are the key segments defining the generalized anxiety disorder market?
The generalized anxiety disorder market covered in this report is segmented –
1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks
2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety
3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety
4) By Social Anxiety: Performance Anxiety, Interaction Anxiety
5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia
6) Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13039&type=smp
Who are the key players steering the development of the generalized anxiety disorder market?
Major companies operating in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.
What emerging trends are influencing the growth of the generalized anxiety disorder market?
Key players in the generalized anxiety disorder market are focusing on the creation of innovative drugs such as MM-120 and successfully obtaining permission for their use in addressing generalized anxiety disorder issues in an effort to cater to the requirements of their current customer base. The plan with novel drugs like MM-120 is to enhance the handling and results of this psychological disorder. For example, in January 2022, Mind Medicine Inc., a US-based biotechnology corporation specializing in psychedelic medicine, was granted permission for an Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). This permit authorizes the company’s Phase IIb trial to optimize the dosage of MM-120 in treating generalized anxiety disorder (GAD). MM-120, a small molecule, functions as a 5-HT2A receptor partial agonist, a receptor that plays an integral role in moderating mood, anxiety, and perception. Furthermore, MM-120 is presumed to impact mental health conditions by elevating serotonin levels in the brain, which could set a precedent for the development of other psychedelic compounds aimed at treating mental health illnesses.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13039
Which regions are most influential in expanding the generalized anxiety disorder market?
North America was the largest region in the generalized anxiety disorder market in 2024. The regions covered in generalized anxiety disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Connected Health and Wellness Solutions Global Market Report 2024
Wellness Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/wellness-supplements-global-market-report
Behavioral and Mental Health Software Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
